Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$437K Buy
112,791
+96,907
+610% +$430K ﹤0.01% 4881
2026
Q1
$74.5K Sell
15,884
-119,319
-88% -$673K ﹤0.01% 5384
2025
Q4
$717K Sell
135,203
-82,458
-38% -$370K ﹤0.01% 4705
2025
Q3
$1M Buy
217,661
+197,228
+965% +$794K ﹤0.01% 4627
2025
Q2
$67.6K Sell
20,433
-636,439
-97% -$1.65M ﹤0.01% 5572
2025
Q1
$1.93M Sell
656,872
-2,636
-0.4% -$7.74K ﹤0.01% 3814
2024
Q4
$1.9M Buy
659,508
+472,322
+252% +$1.31M ﹤0.01% 3691
2024
Q3
$520K Buy
+187,186
New +$456K ﹤0.01% 4805
2024
Q2
Sell
-470,940
Closed -$829K 6422
2024
Q1
$829K Buy
+470,940
New +$628K ﹤0.01% 4462
2022
Q1
Sell
-59,205
Closed -$352K 7383
2021
Q4
$352K Buy
+59,205
New +$461K ﹤0.01% 5379
2021
Q3
Sell
-211,816
Closed -$3.17M 7166
2021
Q2
$3.17M Buy
+211,816
New +$3.09M ﹤0.01% 3373

Other funds holding RERE

Israel Englander's RERE Position: Q2 2026 in Review

Israel Englander increased its ATRenew (RERE) stake by 610% in Q2 2026, buying an estimated $430K and bringing the position to 112,791 shares worth $437K. The position accounts for ﹤0.01% of the portfolio, ranked #4881.

Israel Englander first reported a position in RERE in Q2 2021 and has held it in 11 quarters since. The position peaked at $3.17M in Q2 2021. 76 funds tracked by Wall St. Rank hold RERE as of Q2 2026.

  • Israel Englander held 112,791 shares of ATRenew worth $437K as of Q2 2026.
  • Israel Englander bought 96,907 ATRenew shares in Q2 2026, an estimated $430K.
  • ATRenew made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #4881 holding.
  • Israel Englander first reported a position in ATRenew in Q2 2021 and has held it in 11 quarters since.
  • Israel Englander's ATRenew position peaked at $3.17M in Q2 2021.
  • 76 funds tracked by Wall St. Rank held ATRenew as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.